Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent.
作者信息
Leufkens Hubert G
机构信息
Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, PO Box 80 082, 3508 TB Utrecht, The Netherlands.
出版信息
J Clin Epidemiol. 2022 Feb;142:258-260. doi: 10.1016/j.jclinepi.2021.10.026. Epub 2021 Nov 5.
Abstract
摘要
Zotero 插件